Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

Association between Immune Related Adverse Events and Outcome in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

Background: It has been reported that the occurrence of immune-related adverse events (irAEs) in oncological patients treated with immune-checkpoint inhibitors (ICIs) may be associated with favorable clinical outcome. We reported the clinical correlation between irAEs and the efficacy of ICIs in a r...

Full description

Bibliographic Details
Main Authors: Agnese Paderi, Roberta Giorgione, Elisa Giommoni, Marinella Micol Mela, Virginia Rossi, Laura Doni, Andrea Minervini, Marco Carini, Serena Pillozzi, Lorenzo Antonuzzo
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cancers
Subjects:
renal cell carcinoma
immune checkpoint inhibitors
immune related adverse events (irAEs)
thyroid
cutaneous
biomarker
Online Access:https://www.mdpi.com/2072-6694/13/4/860

Internet

https://www.mdpi.com/2072-6694/13/4/860

Similar Items